Both in Pharmaceuticals
Citius Oncology vs Verrica Pharmaceuticals
Over the past year CTOR returned −66.9% and VRCA returned −3.9%; their daily moves had a correlation of 0.13.
CTOR −66.9% VRCA −3.9%Growth of $1, one year, split-adjusted
| Metric | CTOR | VRCA |
|---|---|---|
| Price | $0.5768 | $3.48 |
| Market cap | $61.0M | $59.8M |
| Today | −5.60% | +0.29% |
| 1 month | −45.1% | −22.0% |
| 6 months | −32.9% | −47.1% |
| Year to date | −42.3% | −58.1% |
| 1 year | −66.5% | −7.4% |
| Revenue growth (YoY) | — | −53.8% |
| Gross margin | 67.1% | 85.0% |
| Net margin | −597.4% | −224.4% |
| P/E (TTM) | — | — |
| Price / sales | 8.6× | 2.0× |
| Net cash | $10.2M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 101.6% | 63.1% |
| Short % of float | 0.8% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).